Alexandra Bouin Peyroutou

Alexandra Bouin Peyroutou has a diverse work experience in the field of business development and scientific research. Alexandra is currently working at Cytel as the Director of Business Development, where they leverage their statistical expertise for adaptive clinical trials. Prior to this, they held the role of Associate Director of Business Development at Cytel, contributing to their pioneering work in adaptive clinical trials and trial design software.

Before joining Cytel, Alexandra worked as a Business Development Manager at Venn Life Sciences, where they offered drug development expertise and clinical trial design services. Alexandra also served as a Business Account Manager at Oncodesign, a French CRO, where they managed a range of activities including drug discovery, pharmacology, and bioanalysis.

Additionally, Alexandra has experience as a Sales Manager at Fluofarma, a French CRO, where they specialized in high content analysis services. Alexandra began their career in scientific research, working as a Scientist in various roles at IRB Montpellier, IBMM, IPBS, and Ecolab. During these roles, they gained experience in stem cell research, oncology pharmacology, neurodegenerative disease studies, and bacterial ecology.

Alexandra Bouin Peyroutou's education history includes a range of degrees and fields of study. Alexandra pursued a Bachelor's degree in Biotechnologies and molecular biology at the University of Pau and Adour Countries from 2008 to 2009. Alexandra then continued their education at the Université Montpellier 2, where they obtained a Master's degree in Biotechnologies and health from 2009 to 2011. Alexandra further expanded their knowledge by pursuing a Master's degree in International Business and Sales from both Mississippi College and IAE Montpellier in 2011 and 2012. Prior to their university studies, they completed a two-year post A-level program at Lycée Saliège, focusing on cellular and molecular biology, microbiology, and biochemistry from 2006 to 2008.